NCT05598983 Non-contact Proactive Remote Monitoring of COPD Exacerbations
| NCT ID | NCT05598983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Life Detection Technologies |
| Condition | COPD Exacerbation |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2023-05-15 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2023-05-15 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are: * Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT? Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.
Eligibility Criteria
Inclusion Criteria: 1. Confirmed diagnosis of COPD 2. 1 or more exacerbation in the last year 3. Aged over 18 years 4. Willing to use monitoring devices and complete study questionnaires 5. Adequate English 6. Signed consent form Exclusion Criteria: 1. Pregnancy 2. BMI greater than 45 kg/m2 3. Nil other, provided inclusion criteria are met.
Contact & Investigator
John Hurst
PRINCIPAL INVESTIGATOR
University College, London
Frequently Asked Questions
Who can join the NCT05598983 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD Exacerbation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05598983 currently recruiting?
Yes, NCT05598983 is actively recruiting participants. Contact the research team at ehowie@distasense.com for enrollment information.
Where is the NCT05598983 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT05598983 clinical trial?
NCT05598983 is sponsored by Life Detection Technologies. The principal investigator is John Hurst at University College, London. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.